Fig. 6. LIN28B-AS1 KO inhibits HepG2 xenograft tumor growth in mice.
LIN28B-AS1 KO (“KO-LIN28B-AS1”) or the control (“CRISPR-C”) HepG2 cells were inoculated s.c. to the flanks of the nude mice; Tumor volumes a and mice body weights c were recorded every 7 days for a total of 42 days. Daily tumor growth was calculated as described b; At Day-14, three HepG2 tumors of each group were isolated, expression of LIN28B-AS1 and listed genes were shown d–f. Bars stand for mean ± standard deviation (SD). *p < 0.05 vs. “CRISPR-C” tumors.